Xiaolan Ling

732 total citations
5 papers, 42 citations indexed

About

Xiaolan Ling is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Xiaolan Ling has authored 5 papers receiving a total of 42 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Surgery, 1 paper in Molecular Biology and 1 paper in Genetics. Recurrent topics in Xiaolan Ling's work include Pancreatic and Hepatic Oncology Research (1 paper), COVID-19 and Mental Health (1 paper) and Cell death mechanisms and regulation (1 paper). Xiaolan Ling is often cited by papers focused on Pancreatic and Hepatic Oncology Research (1 paper), COVID-19 and Mental Health (1 paper) and Cell death mechanisms and regulation (1 paper). Xiaolan Ling collaborates with scholars based in United States, China and Macao. Xiaolan Ling's co-authors include Dajun Yang, Yuan Sun, Ramzi M. Mohammad, Jianyong Chen, Zaneta Nikolovska‐Coleska, Jack Wu, Ayad Al‐Katib, Amro Aboukameel, Shaomeng Wang and Sanjeev Banerjee and has published in prestigious journals such as Drug Discovery Today, BMC Cancer and Cancer Biology & Therapy.

In The Last Decade

Xiaolan Ling

4 papers receiving 41 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Ling United States 3 28 8 6 6 4 5 42
Kévin Uguen France 4 16 0.6× 14 1.8× 6 1.0× 6 1.0× 2 0.5× 11 43
Erle M. Holgersen Canada 3 42 1.5× 4 0.5× 4 0.7× 3 0.5× 4 62
Nurettin İlter Sever Türkiye 4 28 1.0× 2 0.3× 11 1.8× 6 1.0× 2 0.5× 5 45
Xiaoli Ping United States 3 21 0.8× 3 0.4× 2 0.3× 4 0.7× 3 0.8× 6 25
Mital Vasoya United States 3 44 1.6× 2 0.3× 4 0.7× 2 0.3× 5 1.3× 4 53
Vivien A. C. Schoonenberg Japan 3 36 1.3× 2 0.3× 5 0.8× 3 0.5× 3 0.8× 7 43
Mengchi Wang China 2 25 0.9× 3 0.4× 7 1.2× 1 0.2× 4 1.0× 2 32
Gísli Magnússon Iceland 2 18 0.6× 2 0.3× 4 0.7× 3 0.5× 4 1.0× 4 41
Petra Fiesel Germany 3 14 0.5× 3 0.4× 3 0.5× 2 0.5× 3 23
Narges Rezaie United States 3 27 1.0× 3 0.5× 6 1.0× 2 0.5× 7 41

Countries citing papers authored by Xiaolan Ling

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Ling more than expected).

Fields of papers citing papers by Xiaolan Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Ling. The network helps show where Xiaolan Ling may publish in the future.

Co-authorship network of co-authors of Xiaolan Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Ling. A scholar is included among the top collaborators of Xiaolan Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Ling. Xiaolan Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Zeng, Tingting, Xiaolan Ling, Si Chen, et al.. (2025). Prognostic value of nutritional risk assessment indices in patients with digestive system tumors. BMC Cancer. 25(1). 1385–1385.
3.
Bi, F. Christopher, Heather N. Frost, Xiaolan Ling, et al.. (2013). Driving external chemistry optimization via operations management principles. Drug Discovery Today. 19(3). 289–294. 1 indexed citations
4.
Sun, Yuan, Jack Wu, Amro Aboukameel, et al.. (2008). Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo. Cancer Biology & Therapy. 7(9). 1418–1426. 32 indexed citations
5.
Zhang, Yan, Xiongwen Zhang, Xiaolan Ling, et al.. (2007). A novel pan inhibitor of Bcl-2 and Mcl-1 apogossypolone (ApoG2) with superior stability and improved activity against human leukemia and lymphoma cells.. 67. 5182–5182. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026